EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Pharmacological properties and clinical development overview of pertuzumab (genetical recombination), trastuzumab (genetical recombination) and vorhyaluronidase alfa (genetical recombination) (PHESGO® combination for ‍subcutaneous injection MA, IN)

Mariko Sakaeda, Naoki Kotani, Takaaki Yoneya, Yue Zheng, Yuji Habara

Folia Pharmacologica Japonica · 01.07.2024 · 159 (4) · 241-253

DOI: 10.1254/fpj.24022 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Folia Pharmacologica Japonica, erschienen am 01.07.2024. Verfasst von Mariko Sakaeda und 4 weiteren Autor:innen. Beteiligte Einrichtung: CHUGAI PHARMACEUTICAL CO., LTD. Hauptthemen laut MEDLINE: Trastuzumab, Antibodies, Monoclonal, Humanized, Hyaluronoglucosaminidase. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TrastuzumabAntibodies, Monoclonal, HumanizedHyaluronoglucosaminidaseHumansInjections, SubcutaneousBreast NeoplasmsDrug CombinationsClinical Trials as TopicErb-b2 Receptor Tyrosine KinasesFemaleRecombinant ProteinsCell Adhesion Molecules

Substanzen

TrastuzumabAntibodies, Monoclonal, HumanizedHyaluronoglucosaminidaseDrug CombinationsErb-b2 Receptor Tyrosine KinasesRecombinant ProteinsCell Adhesion Moleculespertuzumabhyaluronidase PH-20

Autor:innen und Institutionen

  • CHUGAI PHARMACEUTICAL CO., LTD.

Zitieren

APA

Sakaeda, M., Kotani, N., Yoneya, T., Zheng, Y., & Habara, Y. (2024). Pharmacological properties and clinical development overview of pertuzumab (genetical recombination), trastuzumab (genetical recombination) and vorhyaluronidase alfa (genetical recombination) (PHESGO® combination for ‍subcutaneous injection MA, IN). Folia Pharmacologica Japonica, 159(4), 241-253. https://doi.org/10.1254/fpj.24022

Vancouver

Sakaeda M, Kotani N, Yoneya T, Zheng Y, Habara Y. Pharmacological properties and clinical development overview of pertuzumab (genetical recombination), trastuzumab (genetical recombination) and vorhyaluronidase alfa (genetical recombination) (PHESGO® combination for ‍subcutaneous injection MA, IN). Folia Pharmacologica Japonica. 2024;159(4):241-253. doi:10.1254/fpj.24022

BibTeX
@article{Sakaeda2024,
  author = {Sakaeda, Mariko and Kotani, Naoki and Yoneya, Takaaki and Zheng, Yue and Habara, Yuji},
  title = {Pharmacological properties and clinical development overview of pertuzumab (genetical recombination), trastuzumab (genetical recombination) and vorhyaluronidase alfa (genetical recombination) (PHESGO® combination for ‍subcutaneous injection MA, IN)},
  journal = {Folia Pharmacologica Japonica},
  year = {2024},
  volume = {159},
  number = {4},
  pages = {241--253},
  doi = {10.1254/fpj.24022}
}
Kostenlos starten →